Just One Vote Just One Vote
This year the Supreme Court and its future composition should be a bigger issue than ever. Yet, few people, including, curiously, the Democrats, are talking about it. Regardless, ...
Oct 13, 2004 / Peter Rothberg
James Baker’s Double Life James Baker’s Double Life
Bush's special envoy has a private interest in Iraqi debt, documents reveal.
Oct 12, 2004 / Feature / Naomi Klein
‘Supporting’ McKinley ‘Supporting’ McKinley
This essay, from the October 18, 1900, issue of The Nation, is a special selection from The Nation Digital Archive. If you want to read everything The Nation has ever published on ...
Oct 12, 2004 / The Editors
Kerry a Bleeding Heart? Hardly Kerry a Bleeding Heart? Hardly
Thank you, George W. Bush, for trying to assure me that John Kerry is a liberal. Wish it were so.
Oct 12, 2004 / Column / Robert Scheer
Voting for the First Time Voting for the First Time
A conversation with Utah Phillips.
Oct 12, 2004 / Feature / Carolyn Crane
A Woman of Firsts A Woman of Firsts
When Waangari Maathai got news that she had received the Nobel Peace Prize, she removed her jewelry, knelt down in the dirt and planted seeds of a Kenyan tree known as the Nandi F...
Oct 11, 2004 / Katrina vanden Heuvel
Cheney’s Lamest Excuse Yet Cheney’s Lamest Excuse Yet
What do you do when the excuses you used to "justify" an unwise and unnecessary war are completely discredited. If you're Vice President Dick Cheney, you make up a new one. Chen...
Oct 11, 2004 / John Nichols
Postcard From Kabul Postcard From Kabul
The Afghan presidential election was plagued with fraud and technical errors.
Oct 10, 2004 / Feature / Christian Parenti
Kerry Keeps Threat Alive Kerry Keeps Threat Alive
Bush-Kerry II was a true-to-form middle episode of a yet-to-be-finished trilogy. In Episode I, the newcomer bested the holder of the throne. In the sequel, ...
Oct 9, 2004 / David Corn
The Revolt Against Big Pharma The Revolt Against Big Pharma
In recent months, we've seen a full-scale revolt over the skyrocketing costs of prescription drugs in this country. Two weeks ago, a high-level dissident executive from Pfizer, t...
Oct 8, 2004 / Katrina vanden Heuvel